XBiotech Inc. XBIT · Stock Open XBiotech Inc. in new tab
XBiotech Inc. Analysis (XBIT)
Is XBiotech Inc. a good investment? XBiotech Inc. (XBIT) is currently trading at 2.18 USD.
Earnings Schedule: XBiotech Inc. is expected to release its next earnings report on Aug. 12, 2026. The market consensus estimate for Forward EPS is 0.13.
Investor FAQ
Does XBiotech Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is XBiotech Inc.?
XBiotech Inc. is classified as a Stock. You can compare it against 6 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Aug. 12, 2026. The company currently has a trailing EPS of -1.50.
Company Profile
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
| Year | Total Dividends |
|---|---|
| ▸2021 |
2.50 USD
|
| July 23, 2021 | 2.5000 |
Community Discussion